Arctic Bioscience AS (OSL:ABS)
Norway
· Delayed Price · Currency is NOK 3.400
0.00 (0.00%)
Mar 9, 2026, 2:11 PM CET
Arctic Bioscience AS Market Cap
Arctic Bioscience AS has a market cap or net worth of 91.65 million as of March 9, 2026. Its market cap has increased by 22.64% in one year.
Market Cap
91.65M
Enterprise Value
144.32M
Revenue
45.90M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.40
Market Cap Chart
Since February 24, 2021, Arctic Bioscience AS's market cap has decreased from 668.24M to 91.65M, a decrease of -86.28%. That is a compound annual growth rate of -32.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 91.65M | 3.66% |
| Dec 30, 2025 | 88.42M | 90.44% |
| Dec 30, 2024 | 46.43M | -82.57% |
| Dec 29, 2023 | 266.38M | -7.39% |
| Dec 30, 2022 | 287.63M | -33.50% |
| Dec 30, 2021 | 432.53M | -35.27% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EXACT Therapeutics AS | 110.08M |
| SoftOx Solutions AS | 155.87M |
| Aqua Bio Technology ASA | 23.15M |
| Zelluna ASA | 409.70M |
| Circio Holding ASA | 717.79M |
| Lytix Biopharma AS | 730.55M |
| Nykode Therapeutics AS | 1.03B |
| PCI Biotech Holding ASA | 7.61M |